HGR unknown

back of the envelope valuation., page-9

  1. 3,648 Posts.
    Yes, once FDA "approved" that will help, but the next real drivers will be the significantly reduced cost and time to perform a test and the increased sensitivity of the test.

    So, with just the compelling features (reduced time and cost), OraLine should do Ok.

    IMO of course...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.